Abstract No. 55: Clinical and radiological outcomes following uterine fibroid embolization (UFE) with either beadblock, embospheres, embozenes or gelfoam

Railton, Nick; Bryant, Tim; Burney, Kashif; Stedman, Brian; Hacking, Nigel

doi:10.1016/j.jvir.2009.12.201

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A variety of embolization particles exist, and have most extensively been compared and contrasted in cases of uterine fibroid embolization. 36 While such comparative studies exist for PAE, there is no consensus in terms of best practice. Commonly used particles in PAE are typically polyvinyl alcohol (PVA) polymers (BeadBlock, 10 Boston Scientific, MN), trisacryl gelatin (TAG) polymers (Embosphere, 37 Merit Medical, UT), and polyzene-coated hydrogel microspheres (Embozene, 8 Varian, CA).…”

Section: Controversy No 3: 300-to 500-μm Size Embolic Particles Shoul...mentioning

confidence: 99%

Controversies in Prostate Artery Embolization: Future Best Practice

Goyal

Salem

Mouli

2022

Semin intervent Radiol

View full text Add to dashboard Cite

Prevalence of lower urinary tract symptoms secondary to benign prostatic hyperplasia is correlated with age. Men seeking treatment options with a low side effect profile often turn to prostate artery embolization (PAE). PAE continues to be refined with advanced tools and optimized techniques. Nonetheless, there exist controversies in terms of best practices for the management of lower urinary track symptoms (LUTS) with PAE. These controversies are essential for medical progress. Herein we suggest best practices moving forward based on currently available data. Given extensive safety data, we recommend PAE be considered alongside medical management and as a precursor to surgery. Given demonstrated efficacy across gland sizes, PAE can be performed in a single session, ideally in a hybrid angio-CT suite, without preoperative cross-sectional imaging. PAE should be initially performed with 300- to 500-μm size particles, and instead consider exploring other particles and sizes for repeat PAE. Finally, PAE can also be considered as first-line option for recurrent disease given the efficacy and excellent safety profile. This article is not meant to purport a dogma, but rather to serve as a guide to the experienced practitioner in challenging his or her own biases when performing PAE.

show abstract